AMPL Form 4: Erica Schultz Exercises 10,000 Options, Sells Shares Under 10b5-1
Rhea-AI Filing Summary
Erica Schultz, a director of Amplitude, Inc. (AMPL), reported transactions on 09/15/2025: She exercised an early-exercisable option to purchase 10,000 shares at a $4.19 exercise price and immediately sold 10,000 shares pursuant to a pre-established 10b5-1 trading plan. The sale generated a weighted average sale price of $11.0633 per share, with execution prices ranging from $10.85 to $11.31. Following these transactions, Schultz beneficially owned 79,500 shares subject to outstanding options and 107,406 shares of Class A common stock.
The option vests monthly beginning 12/10/2020 and fully vested on the fourth anniversary; the sale was executed under the 10b5-1 plan adopted 03/12/2025.
Positive
- Exercise of in-the-money options at $4.19 demonstrates leverage capture versus market prices
- Sale executed under a 10b5-1 trading plan, indicating pre-established trading intent and reduced timing concerns
- Transparent disclosure of weighted average sale price and price ranges ($10.85–$11.31)
Negative
- Insider sold 10,000 shares, reducing her immediate shareholdings in AMPL
- Reported beneficial ownership decreased from 117,406 to 107,406 Class A shares following the sale
Insights
TL;DR: Director exercised in-the-money options and sold the exercised shares under a 10b5-1 plan, realizing roughly $70k in gross proceeds.
The director exercised 10,000 options with a $4.19 strike and sold the same number of shares at a weighted average price of $11.0633, indicating a per-share gross gain of about $6.87 before taxes and fees. The sale was executed under a 10b5-1 plan adopted March 12, 2025, and prices ranged $10.85–$11.31. Post-transaction beneficial ownership includes 107,406 Class A shares and 79,500 optioned shares.
TL;DR: Transaction follows standard governance practices: early exercise plus planned sale under a 10b5-1 plan.
The filing discloses that the sale was pursuant to a documented 10b5-1 plan, reducing concerns about opportunistic insider timing. The reporting was executed by an attorney-in-fact and properly signed. The remaining beneficial ownership and outstanding options are disclosed, with vesting schedule noted for transparency.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 10,000 | $4.19 | $42K |
| Sale | Class A Common Stock | 10,000 | $11.0633 | $111K |
Footnotes (1)
- The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 12, 2025. This transaction was executed in multiple trades at prices ranging from $10.8500 to $11.3100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option is early exercisable. 1/48th of the shares subject to the option vest on each monthly anniversary measured from December 10, 2020 (the"Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
